Clinical Evidence Insights from EHRA Congress 2025

This report presents findings from the EHRA Congress held in Vienna from March 30 to April 1, 2025, focusing on advancements in subcutaneous implantable defibrillator (S-ICD) therapy and related technologies. It discusses the largest cohort study on S-ICD therapy in patients with Brugada syndrome, highlighting long-term outcomes and efficacy. The report details the PRAETORIAN score's application in clinical practice, emphasizing its simplification through the intermuscular technique, which eliminates two assessment steps. Additionally, it covers the use of LUX-Dx ICM for remote programming, which reduces clinic workload and unnecessary transmissions. The report also examines dynamic evaluation of atrial fibrillation risk factors using multiple ICD sensors, presenting a combined monitoring score that enhances prediction capabilities. Overall, the document outlines significant clinical insights and implications for improving patient management and device efficacy in cardiac care.